Literature DB >> 17324347

Mechanisms of glucose intolerance in patients with chronic hepatitis C: implications for treatment.

Pierre M Gholam1, Angela F Domingo.   

Abstract

Both diabetes and chronic hepatitis C virus (HCV) infection are common conditions that often coexist in the same subject. Studies seem to confirm the presence of an association between them. Mechanisms leading to HCV-induced insulin resistance and glucose intolerance are beginning to be elucidated. Insulin resistance in the setting of chronic HCV infection could be related etiologically to viral factors but is also often seen with concomitant nonalcoholic fatty liver disease, the hepatic manifestation of the metabolic syndrome. Insulin resistance decreases the likelihood of response to interferon-based therapies and may be an independent risk factor for the progression of HCV-related liver disease.

Entities:  

Year:  2007        PMID: 17324347     DOI: 10.1007/s11908-007-0005-4

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  49 in total

1.  Effects of long-term interferon-alpha treatment on glucose tolerance in patients with chronic hepatitis C.

Authors:  Y Ito; N Takeda; M Ishimori; A Akai; K Miura; K Yasuda
Journal:  J Hepatol       Date:  1999-08       Impact factor: 25.083

2.  A confluence of epidemics: does hepatitis C cause type 2 diabetes?

Authors:  J Everhart
Journal:  Hepatology       Date:  2001-03       Impact factor: 17.425

3.  Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin.

Authors:  N Fujita; M Kaito; M Kai; R Sugimoto; H Tanaka; S Horiike; M Konishi; M Iwasa; S Watanabe; Y Adachi
Journal:  J Viral Hepat       Date:  2006-07       Impact factor: 3.728

4.  Oxidative stress and hepatitis C viral infection.

Authors:  Kazuhiko Koike; Hideyuki Miyoshi
Journal:  Hepatol Res       Date:  2005-12-20       Impact factor: 4.288

5.  Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients.

Authors:  Alba Muzzi; Gioacchino Leandro; Laura Rubbia-Brandt; Richard James; Olivia Keiser; Raffaele Malinverni; Jean-François Dufour; Beat Helbling; Antoine Hadengue; Jean-Jacques Gonvers; Beat Müllhaupt; Andreas Cerny; Mario U Mondelli; Farncesco Negro
Journal:  J Hepatol       Date:  2005-01       Impact factor: 25.083

6.  Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection.

Authors:  S Caronia; K Taylor; L Pagliaro; C Carr; U Palazzo; J Petrik; S O'Rahilly; S Shore; B D Tom; G J Alexander
Journal:  Hepatology       Date:  1999-10       Impact factor: 17.425

7.  Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection.

Authors:  Y Itoh; T Okanoue; N Ohnishi; M Sakamoto; K Nishioji; Y Nakagawa; M Minami; Y Murakami; K Kashima
Journal:  Am J Gastroenterol       Date:  1999-05       Impact factor: 10.864

8.  Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy.

Authors:  R D'Souza; C A Sabin; G R Foster
Journal:  Am J Gastroenterol       Date:  2005-07       Impact factor: 10.864

9.  Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

Authors:  S H Mehta; F L Brancati; M S Sulkowski; S A Strathdee; M Szklo; D L Thomas
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

10.  Glucose intolerance in Chinese patients with chronic hepatitis C.

Authors:  Liang-Kung Chen; Shinn-Jang Hwang; Shih-Tzer Tsai; Jiing-Chyuan Luo; Shou-Dong Lee; Full-Young Chang
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.